Literature DB >> 8304075

Surgical treatment of "hindbrain related" syringomyelia: new data for pathogenesis.

M D Blagodatsky1, S N Larionov, P A Manohin, V A Shanturov.   

Abstract

52 patients with "hindbrain related" syringomyelia underwent surgical treatment. All patients underwent primary reconstructive surgery at the craniovertebral junction. Terminal ventriculostomy was performed as the secondary operation in 2 cases. The surgical treatment arrested progression of signs in 33 (63.5%), stabilized disease in 9 (17%) cases. Postoperative deterioration occurred in 8 (15%) cases. Mortality was 4% (2 patients). Percutaneous or intra-operative injection of myodil and gas into the syrinx, as well as CT, revealed the existence of communication with the 4th ventricle in 14 patients. Investigation of cerebrospinal and syrinx fluid revealed increased level of IgG, IgM or IgA in the syrinx fluid in 16 out of 22 patients. Immunohistological examination of pia mater revealed specific staining for IgG. Thus, syrinx formation may be due to synergic action of hydrodynamic and immunopathological mechanisms. Results indicate that early surgical treatment is preferable to patients with hindbrain anomalies and hydromyelia. We consider primary reconstructive operation at the posterior fossa as the preferred surgical management of "hindbrain related" syringomyelia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8304075     DOI: 10.1007/BF01401127

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  Lumboperitoneal shunt combined with myelotomy for treatment of syringohydromyelia.

Authors:  T S Park; W S Cail; W C Broaddus; M G Walker
Journal:  J Neurosurg       Date:  1989-05       Impact factor: 5.115

2.  Use of the syringoperitoneal shunt in the treatment of syringomyelia.

Authors:  F Lesoin; H Petit; C E Thomas; C Viaud; D Baleriaux; M Jomin
Journal:  Surg Neurol       Date:  1986-02

3.  Considerations in the diagnosis and treatment of syringomyelia and the Chiari malformation.

Authors:  L D Cahan; J R Bentson
Journal:  J Neurosurg       Date:  1982-07       Impact factor: 5.115

4.  Syringoperitoneal shunt for treatment of cord cavitation.

Authors:  M Suzuki; C Davis; L Symon; F Gentili
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

5.  Chiari I malformation with syringomyelia. Evaluation of surgical therapy by magnetic resonance imaging.

Authors:  U Batzdorf
Journal:  J Neurosurg       Date:  1988-05       Impact factor: 5.115

6.  Surgical treatment of syringomyelia: favorable results with syringosubarachnoid shunting.

Authors:  R Padovani; M Cavallo; G Gaist
Journal:  Surg Neurol       Date:  1989-09

7.  Symptomatic Chiari malformations. An analysis of presentation, management, and long-term outcome.

Authors:  G N Dyste; A H Menezes; J C VanGilder
Journal:  J Neurosurg       Date:  1989-08       Impact factor: 5.115

8.  Multicystic syringomyelia treated with a single, non-valved syringoperitoneal shunt: fast and near-complete MRI normalization.

Authors:  K Wester; I F Kjosavik; R Midgard
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

9.  Terminal ventriculostomy for syringomyelia.

Authors:  W J Gardner; H S Bell; P N Poolos; D F Dohn; M Steinberg
Journal:  J Neurosurg       Date:  1977-05       Impact factor: 5.115

Review 10.  On the pathogenesis of syringomyelia: a review.

Authors:  B Williams
Journal:  J R Soc Med       Date:  1980-11       Impact factor: 18.000

View more
  1 in total

Review 1.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.